Alan K. Ikeda

1.2k total citations
20 papers, 614 citations indexed

About

Alan K. Ikeda is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Alan K. Ikeda has authored 20 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Hematology and 6 papers in Genetics. Recurrent topics in Alan K. Ikeda's work include Ubiquitin and proteasome pathways (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Blood groups and transfusion (4 papers). Alan K. Ikeda is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Blood groups and transfusion (4 papers). Alan K. Ikeda collaborates with scholars based in United States, Poland and Germany. Alan K. Ikeda's co-authors include Kathleen M. Sakamoto, Tiffany Simms-Waldrip, Tara L. Lin, Agustı́n Rodrı́guez-González, Cecilia Fu, Theodore B. Moore, Bingxin Li, Bryan Mitton, Xiangshu Xiao and Elliot M. Landaw and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Alan K. Ikeda

18 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan K. Ikeda United States 11 396 156 120 99 84 20 614
Marcelo J. Murai United States 9 596 1.5× 224 1.4× 91 0.8× 46 0.5× 71 0.8× 17 769
Isha Kapoor India 13 376 0.9× 84 0.5× 141 1.2× 107 1.1× 36 0.4× 25 569
Kerstin Maria Kampa-Schittenhelm Germany 12 283 0.7× 155 1.0× 171 1.4× 80 0.8× 32 0.4× 30 516
Yuanying Gong China 10 343 0.9× 99 0.6× 85 0.7× 55 0.6× 31 0.4× 16 520
Manjula Santhanakrishnan United States 11 346 0.9× 210 1.3× 166 1.4× 56 0.6× 54 0.6× 21 666
Chu Myong Seong South Korea 12 360 0.9× 119 0.8× 133 1.1× 36 0.4× 26 0.3× 30 511
Bei Jin China 11 400 1.0× 96 0.6× 122 1.0× 42 0.4× 33 0.4× 15 578
Élodie Richard France 16 474 1.2× 79 0.5× 147 1.2× 63 0.6× 79 0.9× 40 708
Jasmine C. Wong United States 11 284 0.7× 182 1.2× 54 0.5× 61 0.6× 26 0.3× 19 465
Benjamin J. Drapkin United States 13 416 1.1× 70 0.4× 233 1.9× 44 0.4× 113 1.3× 30 659

Countries citing papers authored by Alan K. Ikeda

Since Specialization
Citations

This map shows the geographic impact of Alan K. Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan K. Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan K. Ikeda more than expected).

Fields of papers citing papers by Alan K. Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan K. Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan K. Ikeda. The network helps show where Alan K. Ikeda may publish in the future.

Co-authorship network of co-authors of Alan K. Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Alan K. Ikeda. A scholar is included among the top collaborators of Alan K. Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan K. Ikeda. Alan K. Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ikeda, Alan K., et al.. (2022). Pancreaticoduodenectomy in 11-year-old male with a non-functional pancreatic neuroendocrine tumor. SHILAP Revista de lepidopterología. 88. 102516–102516.
3.
Lal, Ashutosh, Trisha E. Wong, Sioḃán Keel, et al.. (2021). The transfusion management of beta thalassemia in the United States. Transfusion. 61(10). 3027–3039. 32 indexed citations
4.
Johnson, Brittany, Wendy Allen‐Rhoades, Bindi Naik‐Mathuria, et al.. (2020). Primary Renal Ewing Sarcoma in Children and Young Adults. Journal of Pediatric Hematology/Oncology. 42(8). 474–481. 10 indexed citations
5.
Lal, Ashutosh, Trisha E. Wong, Jennifer Andrews, et al.. (2018). Transfusion practices and complications in thalassemia. Transfusion. 58(12). 2826–2835. 23 indexed citations
6.
Niihara, Yutaka, Suvankar Majumdar, Brian Claggett, et al.. (2017). Phase 3 Study of L-Glutamine in Sickle Cell Disease: Analyses of Time to First and Second Crisis and Average Cumulative Recurrent Events. Blood. 130(Suppl_1). 685–685. 4 indexed citations
7.
Simms-Waldrip, Tiffany, et al.. (2015). Invasive fungal infections in pediatric hematopoietic stem cell transplant patients. Infectious Diseases. 47(4). 218–224. 22 indexed citations
8.
Tarantino, Michael D., James B. Bussel, Amy E. Geddis, et al.. (2013). Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP). Blood. 122(21). 3530–3530. 1 indexed citations
9.
Aldana-Masangkay, Grace, Agustı́n Rodrı́guez-González, Tara L. Lin, et al.. (2011). Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells. Leukemia & lymphoma. 52(8). 1544–1555. 42 indexed citations
10.
Panosyan, Eduard H., Alan K. Ikeda, Vivian Y. Chang, et al.. (2011). High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Rescue for Pediatric Brain Tumor Patients: A Single Institution Experience from UCLA. SHILAP Revista de lepidopterología. 2011. 1–11. 7 indexed citations
11.
Xiao, Xiangshu, Bingxin Li, Bryan Mitton, Alan K. Ikeda, & Kathleen M. Sakamoto. (2010). Targeting CREB for Cancer Therapy: Friend or Foe. Current Cancer Drug Targets. 10(4). 384–391. 131 indexed citations
12.
Ikeda, Alan K., Dejah R. Judelson, Noah Federman, et al.. (2010). ABT-869 Inhibits the Proliferation of Ewing Sarcoma Cells and Suppresses Platelet-Derived Growth Factor Receptor β and c-KIT Signaling Pathways. Molecular Cancer Therapeutics. 9(3). 653–660. 17 indexed citations
13.
Buchbinder, David, Daniel S. Levi, Alan K. Ikeda, Kevin Shannon, & Theodore B. Moore. (2009). Inappropriate Sinus Tachycardia After Hematopoietic Stem Cell Transplantation. Journal of Pediatric Hematology/Oncology. 32(1). 15–18. 1 indexed citations
14.
Rodrı́guez-González, Agustı́n, Tara L. Lin, Alan K. Ikeda, et al.. (2008). Role of the Aggresome Pathway in Cancer: Targeting Histone Deacetylase 6–Dependent Protein Degradation. Cancer Research. 68(8). 2557–2560. 142 indexed citations
15.
Simms-Waldrip, Tiffany, Agustı́n Rodrı́guez-González, Tara L. Lin, et al.. (2008). The aggresome pathway as a target for therapy in hematologic malignancies. Molecular Genetics and Metabolism. 94(3). 283–286. 56 indexed citations
16.
Ikeda, Alan K., et al.. (2008). Evaluating pharmacokinetics and pharmacodynamics of intravenous busulfan in pediatric patients receiving bone marrow transplantation. Pediatric Transplantation. 13(8). 971–976. 10 indexed citations
17.
Moore, Theodore B., et al.. (2008). Obesity in Survivors of Childhood Hematopoietic Stem Cell Transplantation.. Blood. 112(11). 2130–2130. 1 indexed citations
18.
Rodrı́guez-González, Agustı́n, Tiffany Simms-Waldrip, Alan K. Ikeda, et al.. (2008). Tubacin, An Inhibitor of HDAC6, Induces Apoptosis of Acute Lymphoblastic Leukemia Cells in Vitro and in Vivo through a Na+/K+ATPase-Dependent Pathway.. Blood. 112(11). 1923–1923. 2 indexed citations
19.
Ikeda, Alan K., Deepa Shankar, Motonobu Watanabe, et al.. (2006). Molecular targets and the treatment of myeloid leukemia. Molecular Genetics and Metabolism. 88(3). 216–224. 26 indexed citations
20.
Ikeda, Alan K., et al.. (2006). FMS-Like Tyrosine Kinase 3 in Normal Hematopoiesis and Acute Myeloid Leukemia. Stem Cells. 24(5). 1174–1184. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026